Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022.
Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Chung JR, Rogier E, Coughlin MM, Flannery B. Sumner KM, et al. Among authors: zimmerman rk. J Infect Dis. 2024 Feb 23:jiae090. doi: 10.1093/infdis/jiae090. Online ahead of print. J Infect Dis. 2024. PMID: 38390968
Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network.
Tartof SY, Xie F, Yadav R, Wernli KJ, Martin ET, Belongia EA, Gaglani M, Zimmerman RK, Talbot HK, Thornburg N, Flannery B; US Flu VE Network Investigators. Tartof SY, et al. Among authors: zimmerman rk. medRxiv [Preprint]. 2023 Jan 11:2023.01.10.23284397. doi: 10.1101/2023.01.10.23284397. medRxiv. 2023. PMID: 36711929 Free PMC article. Updated. Preprint.
Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network.
Tartof SY, Xie F, Yadav R, Wernli KJ, Martin ET, Belongia EA, Gaglani M, Zimmerman RK, Talbot HK, Thornburg N, Flannery B; US Flu VE Network Investigators. Tartof SY, et al. Among authors: zimmerman rk. Influenza Other Respir Viruses. 2023 May;17(5):e13143. doi: 10.1111/irv.13143. Influenza Other Respir Viruses. 2023. PMID: 37246146 Free PMC article.
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022.
Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Chung JR, Rogier E, Coughlin MM, Flannery B. Sumner KM, et al. Among authors: zimmerman rk. medRxiv [Preprint]. 2023 Sep 23:2023.09.21.23295919. doi: 10.1101/2023.09.21.23295919. medRxiv. 2023. PMID: 37790578 Free PMC article. Updated. Preprint.
Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults.
Hughes K, Middleton DB, Nowalk MP, Balasubramani GK, Martin ET, Gaglani M, Talbot HK, Patel MM, Ferdinands JM, Zimmerman RK, Silveira FP; HAIVEN Study Investigators. Hughes K, et al. Among authors: zimmerman rk. Clin Infect Dis. 2021 Dec 6;73(11):e4353-e4360. doi: 10.1093/cid/ciaa1927. Clin Infect Dis. 2021. PMID: 33388741 Free PMC article.
357 results